How to Effectively Reach People with Your Science?
A Special Session at the AACR Annual Meeting 2024 offered researchers advice on better ways to communicate science to...
A Special Session at the AACR Annual Meeting 2024 offered researchers advice on better ways to communicate science to...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
When Abigail Johnston’s first child entered preschool six years ago, a vigilant pediatrician recommended an unusual strategy for minimizing...
Due to advances in screening and treatment, the survival rate for patients with breast cancer has increased in recent decades. However, this progress...
Thirty years ago, Mary-Claire King, PhD, FAACR, and colleagues were the first to demonstrate that breast cancer could be genetically inherited....
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
The U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called fam-trastuzumab deruxtecan-nxki (Enhertu) for treating...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...